Abstract:Previous studies have yielded controversial results related to the contribution of interleukin 10 (IL-10) gene polymorphisms (IL-10 -592C/A, IL-10 -1082G/A, and IL-10 -819C/T) in the progression of cardiovascular disease (CVD). Thus, we performed a meta-analysis to summarize this situation. Eligible studies were retrieved by searching PubMed, Embase, Web of Science, and Cochrane Library with the last search up to July 7, 2015. Data were pooled by odds ratios (ORs) and their 95% confidence intervals (CIs). False-positive report probability (FPRP) analysis was conducted for all significant findings. Genotype-based mRNA expression analysis was also performed using data from 270 individuals with different ethnicities. Finally, 19 studies for IL-10 -592C/A polymorphism (7284 cases and 7469 controls), 21 studies for IL-10 -1082G/A polymorphism (8263 cases and 5765 controls), and 12 studies for IL-10 -819C/T polymorphism (4502 cases and 3190 controls) were included in the meta-analyses. With respect to IL-10 -819C/T polymorphism, statistically significant decreased CVD risk was found when all studies were pooled into the meta-analysis (T vs C: OR = 0.91, 95% CI = 0.84–0.98; TT + TC vs CC: OR = 0.90, 95% CI = 0.81–1.00). Subgroup analyses stratified by disease subtype suggested the -819C/T polymorphism was significantly associated with a decreased CAD risk (T vs C: OR = 0.90, 95% CI = 0.83–0.97; TT vs CC: OR = 0.81, 95% CI = 0.66–1.00; TT vs TC + CC: OR = 0.82, 95% CI = 0.69–0.98; TT + TC vs CC: OR = 0.89, 95% CI = 0.80–0.99), which was noteworthy finding as evaluated by FPRP. However, with regard to IL-10 -592C/A and IL-10 -1082G/A polymorphisms, no significant association with CVD risk was observed in the overall and subgroup analyses. In conventional meta-analyses, the results suggested that IL-10 -819C/T polymorphism was associated with decreased risk of CVD, especially CAD outcome, whereas IL-10 -592C/A and IL-10 -1082G/A polymorphisms might have no influence on the susceptibility of CVD. However, trial sequential analysis does not allow us to draw any solid conclusion for the association between IL-10 -592C/A or IL-10 -1082G/A polymorphism and CVD risk. Further large and well-designed studies are still needed.

Polymorphisms of interleukin-1 and interleukin-6 genes on the risk of ischemic stroke in a meta-analysis.

Polymorphisms of Interleukin-10 Genes on the Risk of Ischemic Stroke in a Meta-Analysis.

Association of Interleukin-1 Gene Cluster Polymorphisms with Ischemic Stroke in A Chinese Population

A novel tailed primers protocol to identify the association of IL-4 and IL-1RN (receptor antagonist) gene variable number of tandem repeats polymorphisms with ischemic stroke in Chinese Han population.

The Association of Functional Polymorphisms of IL-6 Gene Promoter with Ischemic Stroke: Analysis in Two Chinese Populations.

Interleukin-18 Gene Promoter 607A Polymorphism, but Not 137C Polymorphism, is a Protective Factor for Ischemic Stroke in the Chinese Population: A Meta-Analysis.

Common polymorphisms in the interleukin-6 gene and myocardial infarction risk: a meta-analysis.

Linkage and Association Between Interleukin-6 Gene Polymorphisms and Ischemic Stroke: a Family-Based Study in the Northern Chinese Han Population.

Genetic polymorphisms of interleukin-6 gene and susceptibility to coronary artery disease in Chinese population: Evidence based on 4582 subjects

Lack of an Association Between Interleukin-6-174g/C Polymorphism and Circulating Interleukin-6 Levels in Normal Population: A Meta-Analysis

Interleukin-18 promoter polymorphisms and risk of ischemic stroke

Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects

Interleukin-6 gene -572 G > C polymorphism and myocardial infarction risk

Meta-analysis of the correlation between IL-6 -174 G/C polymorphism and polycystic ovarian syndrome.

Association between interleukin-6 gene -174 G/C polymorphism and the risk of coronary heart disease: a meta-analysis of 20 studies including 9619 cases and 10,919 controls

Polymorphism of IL6 Receptor Gene is Associated with Ischaemic Stroke in Patients with Metabolic Syndrome.

IL-6 gene polymorphisms and CAD risk: a meta-analysis

Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High

Association Between 3 Il-10 Gene Polymorphisms and Cardiovascular Disease Risk Systematic Review with Meta-Analysis and Trial Sequential Analysis

Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population

Identification of Functional Genetic Polymorphisms at IL-10 Promoter Region and their Association with Risk of Ischemic Stroke in Chinese Han Population